Last week, PBC Biomed Inc welcomed the Mochida Pharmaceuticals Ltd team to their Epicenter Memphis office for a courtesy visit.
The delegation included Mochida Pharmaceuticals Ltd board member Mr. Chu Sakata-san, who recently transitioned from his role as Vice President of the Mochida Group to Corporate Advisor.
Discussion on the day focused on the shared appreciation for the long-standing business cooperation between our organizations, as well as an overview of PBC Inc.’s history, current structure, and exciting future pipeline.
Pictured from left to right below:
– Dr Thomas A. (Toney) Russell MD – President, PBC Biomed Inc
– Mark McMahan – Chief Commercial Officer, PBC Biomed Limited
– Patrick Rickard – Financial Controller International PBC Biomed Limited
– Mr. Chu Sakata-san – Mochida Pharmaceutical Co. Ltd
– Fumihiko Mori – Mochida Pharmaceutical Co. Ltd
– Nozomu Watanabe – Mochida Pharmaceutical Co. Ltd
Looking forward to seeing what 2026 brings for our US business!
#PBCBiomedInc#MochidaPharmaceuticalsUS#Acceleratingmedicalinnovation

Mochida Pharmaceuticals Visit
Search News Items
Categories
- Awards (11)
- Biomaterials (24)
- Biovet (13)
- Bone Adhesive (20)
- Bone Disease Solution (4)
- Bone Healing (14)
- Certification (1)
- Client (2)
- Collaboration (30)
- Conferences (24)
- Contract Manufacturing (3)
- Day One Trauma Charity (4)
- Development (21)
- Events (65)
- Government Funding (3)
- Lectures (7)
- Medical Devices (9)
- Medical Implants (6)
- Memphis Office (8)
- New Hire (11)
- On TV/Radio (2)
- Partnership (6)
- Press Release (8)
- Publications (7)
- ReFeelNerveRepairSolution (12)
- Regenerative Medicine (15)
- Relationship-building (18)
- Research (18)
- Sports & Social (3)
- Sports Partners (9)
- Student Placements (3)
- Uncategorized (6)
- Upcoming Events (6)
- US Office (6)

